MeSH tree: D02.241.081.114.937
A research team led by Matthew Nystoriak, Ph.D., associate professor of biomedical research and translational medicine at Masonic Medical Research Institute (MMRI), has uncovered groundbreaking insights into heart health ...
Jan 6, 2025
0
21
A component of the keto diet appears to boost the powers of immunotherapy in treating cancer, a new study finds.
Dec 9, 2024
0
18
Ketone bodies, produced by the body to provide fuel during fasting, have roles in regulating cellular processes and aging mechanisms beyond energy production. Research at the Buck Institute shows that ketone bodies can best ...
Dec 2, 2024
0
52
Laryngeal dystonia (LD), a rare neurological disease that significantly impacts a person's ability to speak due to uncontrollable vocal cord spasms, can have a debilitating effect on a person's social life, employment and ...
Nov 20, 2024
0
19
Researchers at Baylor College of Medicine, Stanford University School of Medicine and collaborating institutions report in the journal Cell the discovery of BHB-Phe, a novel compound produced by the body that regulates appetite ...
Nov 12, 2024
0
160
Gamma hydroxybutyrate (GHB)-related deaths in Australia have risen sharply in the last decade with use of the "party drug" extending beyond the clubbing scene to a broader population, according to new research from the National ...
Sep 25, 2024
0
66
The ketogenic diet has its fanatics and detractors among dieters, but either way, the diet has a scientifically documented impact on memory in mice. While uncovering how the high fat, low carbohydrate diet boosts memory in ...
Jun 18, 2024
0
319
A new research paper titled "The impact of continuous and intermittent ketogenic diets on cognitive behavior, motor function, and blood lipids in TgF344-AD rats" has been published in Aging.
Apr 17, 2024
0
48
A new study from researchers at the University of California, Davis, shows that a ketogenic diet significantly delays the early stages of Alzheimer's-related memory loss in mice. This early memory loss is comparable to mild ...
Mar 19, 2024
0
309
The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to be taken once ...
May 5, 2023
0
89
